We sincerely thank Dr. Borja Aguinagalde and colleagues for their insightful commentary (1) on our article published in the Journal of Clinical Oncology in 2024, which highlighted the long-term benefits of early electronic patient-reported outcome (ePRO)-based symptom management after lung cancer surgery (2). We appreciate their recognition of ePRO’s value in postoperative care, especially as telemedicine use has increased during the coronavirus disease 2019 (COVID-19) pandemic. As they rightly noted, integrating ePRO into routine practice faces multifaceted barriers (3).